Your shopping cart is currently empty

JN122 is a spiroindoline-containing molecule that acts as an MDM2 inhibitor. It disrupts the MDM2/p53 protein-protein interaction, exhibiting potent antitumor effects in vivo. JN122 demonstrates antiproliferative activity, with IC50 values of 39.6 nM in HCT-116 cells and 4.28 μM in HEK-293 cells. It induces the activation of p53 and its target genes, halts cell cycle progression, and triggers apoptosis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | JN122 is a spiroindoline-containing molecule that acts as an MDM2 inhibitor. It disrupts the MDM2/p53 protein-protein interaction, exhibiting potent antitumor effects in vivo. JN122 demonstrates antiproliferative activity, with IC50 values of 39.6 nM in HCT-116 cells and 4.28 μM in HEK-293 cells. It induces the activation of p53 and its target genes, halts cell cycle progression, and triggers apoptosis. |
| Formula | C33H37Cl2N3O4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.